Devonian Advances Thykamine™ Patent Strategy with Proprietary Fingerprint and Robust Manufacturing Controls

Devonian Health Group Inc. ("Devonian" or the Company) (TSXV: GSD) (OTCQB: DVHGF) today announced that a proprietary ...

Tradewinds Universal Secures $10 Million Equity Line to Accelerate Roll-Up of High-Revenue Assets

Tradewinds Universal (OTC: TRWD), a fully reporting holdings company focused on acquiring revenue-producing assets, today announced that it has secured a $10 million Equity Line of Credit (“ELOC”) ...
Morning Overview on MSN

This tiny animal is smaller than your thumb but lethal enough to kill you

Some of the most dangerous creatures on the planet are not the ones with the sharpest teeth or the largest bodies. They are, ...

Johnson & Johnson: FDA approves RYBREVANT FASPRO (amivantamab and hyaluronidase-lpuj) as the only EGFR-targeted therapy that can be administered once a month

Monthly dosing reduces treatment visits while maintaining established safety and efficacy1,2 Builds on RYBREVANT FASPRO FDA approval to deliver the simplest and fastest ...